ARA-290 (Cibinetide)
Overview
ARA-290 is engineered from a region of erythropoietin (EPO) responsible for tissue-protective signaling, separated from the part that stimulates red blood cell production. That distinction is the whole point of the compound: it’s studied for nerve-related pain and tissue repair without the blood-thickening risk that comes with EPO itself.
Dosing
See the general Dosing Guide for reconstitution and administration basics.
Further Reading
This page is a general summary, not a literature review. For primary research on ARA-290 (Cibinetide), the National Library of Medicine's PubMed database is the standard starting point for peer-reviewed studies:
Search PubMed for ARA-290 (Cibinetide) research →